Table 2.
Author | Bendamustine plus | N | ORR(%) | CR(%) | PR(%) |
---|---|---|---|---|---|
Kirchner et al (2001) | Fludarabine + rituximab | 25 | 76 | 28 | 48 |
Weide et al (2004) | Mitoxantrone + rituximab | 54 | 96 | 41 | 55 |
Rummel et al (2005) | Rituximab | 63 | 90 | 60 | 30 |
Robinson et al (2005) | Rituximab | 54 | 84 | 21 | 63 |
Van der Jagt et al (2006) | Rituximab | 66 | 94 | 41 | 53 |
Weide et al (2007) | Mitoxantrone + rituximab | 57 | 89 | 35 | 54 |
Abbreviations: CR, complete remission; ORR, overal response rate; PR, partial remission.